News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Conference News PCR London Valves 2022 Real-World TEER Outcomes in Primary MR Make Gains, but Questions Remain Shelley Wood December 01, 2022
News Conference News PCR London Valves 2022 Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains Shelley Wood November 28, 2022
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Conference News CRT 2018 Early Low-Risk TAVR Data Reassure, but Durability Questions Remain Michael O'Riordan March 05, 2018
News Conference News AHA 2017 ‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry Todd Neale November 22, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016
News Conference News EuroPCR 2016 As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease Shelley Wood May 18, 2016